Registry of pulmonary hypertension in Poland

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The BNP-PL is a multicenter, observational registry that follows patients diagnosed with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension in Poland. It aims to investigate the clinical course and management of these conditions by collecting data from accredited pulmonary hypertension centers across the country. The data is managed by Jagiellonian University Medical College and focuses on describing current practices and outcomes without impacting patient diagnosis or treatment. Data collection is conducted through an electronic platform, ensuring patient confidentiality.

Why it matters

Who can join: the full rules

Inclusion Criteria:

Patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension diagnosed after 1st March 2018 (incident cases) who:

* are aged \> 3 months at the time of enrollment
* fulfill the following hemodinamic criteria: mean pulmonary arterial pressure (mPAP) of 25 mm Hg or more, mean pulmonary arterial wedge pressure (PAWP) or left ventricular end-diastolic pressure (PVEDP) of 15 mm Hg or less, pulmonary vascular resistance (PVR) of 3 Woods.

Patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension diagnosed before 1st March 2018 (prevalent cases) who:

* are aged \> 3 months at the time of enrollment
* fulfill the following hemodinamic criteria: mean pulmonary arterial pressure (mPAP) of 25 mm Hg or more, mean pulmonary arterial wedge pressure (PAWP) or left ventricular end-diastolic pressure (PVEDP) of 15 mm Hg or less, pulmonary vascular resistance (PVR) of 3 Woods

Where it's running

• Krakowski Szpital Specjalistyczny im. Jana Pawła II
  Krakow, Poland Recruiting

Study contacts

• Principal investigator: Grzegorz Kopeć, MD, Phd — Krakowski Szpital Specjalistyczny im. Jana Pawła II
• Study coordinator: Grzegorz Kopeć
• Email: grzegorzkrakow1@gmail.com
• Phone: +48 12 614 33 99

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Registry and biorepository for pulmonary hypertension patients

  This study is setting up a collection of health information and blood samples from people with pulmonary hypertension to help researchers learn more about the disease and improve treatments.

  Recruiting University of Kansas Medical Center · Kansas City, Kansas · NCT04808596

• Registry for patients with pulmonary hypertension

  This study collects information from people with pulmonary hypertension to see how they are diagnosed and treated, and to find ways to improve their care.

  Recruiting at 51 sites Pulmonary Hypertension Association, Inc. · Phoenix, Arizona and 51 other locations · NCT04071327

• Pulmonary Embolism Registry from Emergency Care to Long-Term Follow-Up

  This registry follows adults with acute pulmonary embolism to see how care is given in the real world and what happens over time.

  Recruiting at 16 sites Azienda Ospedaliero-Universitaria Careggi · Bagno a Ripoli, Tuscany and 15 other locations · NCT07855679

• Understanding how low-load leg exercises affect muscle and blood flow in PAH patients

  This substudy tests whether a gentle leg exercise program can change blood flow and oxygen use in the calf muscles of adults with pulmonary arterial hypertension.

  Recruiting University of Pennsylvania · Philadelphia, Pennsylvania · NCT07781709

• Nailfold Capillaroscopy in Pulmonary Hypertension

  This study tests whether nailfold capillary scans correlate with invasive lung blood pressure measurements and whether these patterns change with PH treatment.

  Recruiting University of Glasgow · Clydebank, West Dunbartonshire · NCT07768644

• Sotatercept in Japanese children with pulmonary arterial hypertension

  This study tests whether sotatercept is safe and well tolerated in Japanese children with PAH when added to standard PAH treatment.

  Recruiting at 3 sites Phase 2 Merck Sharp & Dohme LLC · Izumi, Osaka and 2 other locations · NCT07646860

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.